IQV

IQV

USD

IQVIA Holdings Inc. Common Stock

$211.410+0.550 (0.261%)

リアルタイム価格

Healthcare
Diagnostics & Research
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$210.860

高値

$215.940

安値

$209.090

出来高

1.49M

企業ファンダメンタルズ

時価総額

36.0B

業種

Diagnostics & Research

United States

取引統計

平均出来高

1.44M

取引所

NYQ

通貨

USD

52週レンジ

安値 $134.65現在値 $211.410高値 $225.91

AI分析レポート

最終更新: 2025年11月1日
AIによる生成データソース: Yahoo Finance, Bloomberg, SEC

IQVIA Holdings (IQV): Riding a Wave of Analyst Upgrades After a Monumental Price Surge

November 1, 2025, 10:56 AM EDT

The Analyst Drumbeat: A Chorus of Confidence Lifts IQV

The story surrounding IQVIA in late October became incredibly clear and loud. On a single day, October 29th, a torrent of positive revisions came from Wall Street's top analysts. It wasn't just one or two voices; it was a powerful consensus. Baird upgraded the stock from Neutral to Outperform. Heavyweights like JP Morgan, UBS, Stifel, and Truist Securities all reiterated their bullish stances while substantially raising their price targets.

Here's a quick look at the new targets:

  • Citigroup: Raised to $230
  • UBS: Raised to $250
  • Stifel: Raised to $254
  • JP Morgan: Raised to $255
  • Baird: Raised to $258
  • Truist Securities: Raised to $265

This unified vote of confidence from the analyst community is a significant event. It suggests that recent performance or forward guidance has fundamentally shifted their perception of the company's value, creating a powerful narrative that has clearly caught the market's attention.

From Sideways Chop to a Vertical Leap: Decoding IQV's October Breakout

Looking at IQVIA's stock chart over the last three months tells a tale of two distinct periods. August and September were characterized by choppy, sideways trading, with the stock struggling to find direction and bouncing between roughly $176 and $193. There was no real conviction.

Then October arrived.

The first day of the month saw the stock explode, gapping up from around $190 to over $203 on massive volume. This wasn't a gradual climb; it was a definitive statement from buyers. After consolidating those gains for a few weeks, another powerful surge began around October 20th, launching the stock from the mid-$200s to a peak of $225. The price has since settled around the $216 level. This pattern--a sharp breakout on heavy volume followed by consolidation--is a classic sign of strength and renewed market interest. The stock has built a new, higher foundation.

The Digital Crystal Ball: What AI Sees for IQV's Next Move

The current momentum is not just visible on the chart; it's also being confirmed by predictive models. An AI forecast projects continued strength in the immediate future, with anticipated gains of 1.64%, 2.77%, and 3.23% over the next three trading days. The model shows high confidence in this upward trend, projecting a potential target price near $229.71.

This bullish short-term outlook, however, runs into a notable headwind: the company's fundamentals. While technical signals and news sentiment are flashing green, the company carries a high debt-to-equity ratio of over 240%. This is a significant long-term risk factor. The situation presents a classic conflict for investors--powerful, news-driven momentum versus underlying financial leverage that cannot be ignored.

The Bottom Line

For now, momentum is in the driver's seat for IQV. The combination of a technical breakout, a tidal wave of positive analyst ratings, and supportive AI predictions creates a compelling case for a short-term trade. This is not a "buy and hold forever" scenario, especially given the high debt load. Instead, it appears to be an opportunity for nimble traders looking to ride the current wave of positive sentiment.

A strategic approach could involve considering entry points around the current price levels of $216 to $217. The data suggests a clear profit target near $228.75, just shy of the AI's projection. To manage risk, a stop-loss order around $194.81 would protect against a sudden reversal that erases the recent breakout gains. This strategy is best suited for an investor with a short-term horizon of one to two weeks who is comfortable acting on clear momentum signals while respecting defined risk parameters.


Disclaimer: This report is for informational purposes only and does not constitute financial, investment, or trading advice. The analysis is based solely on the data provided and is not a guarantee of future performance. All investing involves risk, including the possible loss of principal. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

関連ニュース

Analyst Upgrades

TD Cowen Downgrades IQVIA Hldgs to Hold, Raises Price Target to $215

TD Cowen analyst Charles Rhyee downgrades IQVIA Hldgs from Buy to Hold and raises the price target from $206 to $215.

もっと見る
TD Cowen Downgrades IQVIA Hldgs to Hold, Raises Price Target to $215
Analyst Upgrades

Citigroup Maintains Neutral on IQVIA Hldgs, Raises Price Target to $230

Citigroup analyst Patrick Donnelly maintains IQVIA Hldgs with a Neutral and raises the price target from $200 to $230.

もっと見る
Citigroup Maintains Neutral on IQVIA Hldgs, Raises Price Target to $230
Analyst Upgrades

UBS Maintains Buy on IQVIA Hldgs, Raises Price Target to $250

UBS analyst Dan Leonard maintains IQVIA Hldgs with a Buy and raises the price target from $225 to $250.

もっと見る
UBS Maintains Buy on IQVIA Hldgs, Raises Price Target to $250
Analyst Upgrades

Stifel Maintains Buy on IQVIA Hldgs, Raises Price Target to $254

Stifel analyst Shlomo Rosenbaum maintains IQVIA Hldgs with a Buy and raises the price target from $234 to $254.

もっと見る
Stifel Maintains Buy on IQVIA Hldgs, Raises Price Target to $254
Analyst Upgrades

JP Morgan Maintains Overweight on IQVIA Hldgs, Raises Price Target to $255

JP Morgan analyst Casey Woodring maintains IQVIA Hldgs with a Overweight and raises the price target from $177 to $255.

もっと見る
JP Morgan Maintains Overweight on IQVIA Hldgs, Raises Price Target to $255
Analyst Upgrades

Truist Securities Reiterates Buy on IQVIA Hldgs, Raises Price Target to $265

Truist Securities analyst Jailendra Singh reiterates IQVIA Hldgs with a Buy and raises the price target from $235 to $265.

Analyst Upgrades

Baird Upgrades IQVIA Hldgs to Outperform, Raises Price Target to $258

Baird analyst Eric Coldwell upgrades IQVIA Hldgs from Neutral to Outperform and raises the price target from $224 to $258.

AI予測Beta

AI推奨

強気

更新日時: 2025年11月4日 20:52

弱気中立強気

74.8% 信頼度

リスクと取引

リスクレベル3/5
中リスク
適しているのは
保守的
取引ガイド

エントリーポイント

$215.57

利確

$228.72

損切り

$194.81

主要因子

PDI 6.4はMDI 4.0の上にあり、ADX 18.1とともに強気トレンドを示唆しています
現在の価格はサポートレベル(215.28ドル)に非常に接近しており、強力な買い機会を示唆しています
出来高は平均(18,638)の7.4倍で、極めて強い買い圧力を示しています
MACD 0.2504はシグナルライン0.1889の上にあり、強気クロスオーバーを示しています

最新情報を入手

価格アラートを設定し、AI分析の更新とリアルタイム市場ニュースを受け取る。